XTL Biopharmaceuticals Ltd. (XTLB.TA)
ILA 4.8
(4.35%)
ILA 4.8
(4.35%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 206 Thousand USD | 10.16% |
| 2022 | 187 Thousand USD | -85.45% |
| 2021 | 1.28 Million USD | 405.91% |
| 2020 | 254 Thousand USD | 9.48% |
| 2019 | 232 Thousand USD | -8.3% |
| 2018 | 253 Thousand USD | -91.47% |
| 2017 | 2.96 Million USD | 799.09% |
| 2016 | 330 Thousand USD | -24.31% |
| 2015 | 436 Thousand USD | -54.82% |
| 2014 | 965 Thousand USD | -21.54% |
| 2013 | 1.23 Million USD | -25.99% |
| 2012 | 1.66 Million USD | 132.45% |
| 2011 | 715 Thousand USD | -25.75% |
| 2010 | 963 Thousand USD | 36.02% |
| 2009 | 708 Thousand USD | -64.67% |
| 2008 | 2 Million USD | -63.98% |
| 2007 | 5.56 Million USD | 34.37% |
| 2006 | 4.14 Million USD | 6.18% |
| 2005 | 3.89 Million USD | -35.25% |
| 2004 | 6.02 Million USD | 41.86% |
| 2003 | 4.24 Million USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 223 Thousand USD | 8.25% |
| 2023 Q1 | 241 Thousand USD | 28.88% |
| 2023 FY | 206 Thousand USD | 10.16% |
| 2023 Q4 | 206 Thousand USD | 27.16% |
| 2023 Q3 | 162 Thousand USD | -0.61% |
| 2023 Q2 | 163 Thousand USD | -32.37% |
| 2022 Q2 | 194 Thousand USD | -75.03% |
| 2022 FY | 187 Thousand USD | -85.45% |
| 2022 Q1 | 777 Thousand USD | -39.53% |
| 2022 Q4 | 187 Thousand USD | 22.22% |
| 2022 Q3 | 153 Thousand USD | -21.13% |
| 2021 Q3 | 3.77 Million USD | 2.86% |
| 2021 FY | 1.28 Million USD | 405.91% |
| 2021 Q1 | 2.94 Million USD | 1059.06% |
| 2021 Q2 | 3.67 Million USD | 24.69% |
| 2021 Q4 | 1.28 Million USD | -65.97% |
| 2020 Q1 | 244 Thousand USD | 5.17% |
| 2020 Q3 | 182 Thousand USD | -6.19% |
| 2020 Q4 | 254 Thousand USD | 39.56% |
| 2020 FY | 254 Thousand USD | 9.48% |
| 2020 Q2 | 194 Thousand USD | -20.49% |
| 2019 Q1 | 236 Thousand USD | -6.72% |
| 2019 Q3 | 200 Thousand USD | -1.48% |
| 2019 Q2 | 203 Thousand USD | -13.98% |
| 2019 FY | 232 Thousand USD | -8.3% |
| 2019 Q4 | 232 Thousand USD | 16.0% |
| 2018 Q1 | 232 Thousand USD | -92.18% |
| 2018 Q3 | 197 Thousand USD | -0.51% |
| 2018 Q4 | 253 Thousand USD | 28.43% |
| 2018 FY | 253 Thousand USD | -91.47% |
| 2018 Q2 | 198 Thousand USD | -14.66% |
| 2017 Q3 | 3.2 Million USD | -36.93% |
| 2017 Q1 | 4.29 Million USD | 1201.21% |
| 2017 FY | 2.96 Million USD | 799.09% |
| 2017 Q4 | 2.96 Million USD | -7.43% |
| 2017 Q2 | 5.08 Million USD | 18.35% |
| 2016 Q1 | 372.00 USD | -99.91% |
| 2016 FY | 330 Thousand USD | -24.31% |
| 2016 Q4 | 330 Thousand USD | 142757.14% |
| 2016 Q3 | 231.00 USD | -99.91% |
| 2016 Q2 | 258 Thousand USD | 69254.84% |
| 2015 FY | 436 Thousand USD | -54.82% |
| 2015 Q4 | 436 Thousand USD | 66.41% |
| 2015 Q3 | 262 Thousand USD | 13.42% |
| 2015 Q2 | 231 Thousand USD | 0.0% |
| 2015 Q1 | - USD | -100.0% |
| 2014 Q1 | 1.31 Million USD | 6.91% |
| 2014 FY | 965 Thousand USD | -21.54% |
| 2014 Q2 | 1.37 Million USD | 4.56% |
| 2014 Q3 | 1.21 Million USD | -11.93% |
| 2014 Q4 | 965 Thousand USD | -20.31% |
| 2013 Q1 | 1.59 Million USD | 12161.54% |
| 2013 FY | 1.23 Million USD | -25.99% |
| 2013 Q4 | 1.23 Million USD | -5.53% |
| 2013 Q3 | 1.3 Million USD | -5.79% |
| 2013 Q2 | 1.38 Million USD | -13.3% |
| 2012 Q1 | 1 Million USD | 59.14% |
| 2012 Q4 | 13 Thousand USD | -98.24% |
| 2012 Q2 | 832 Thousand USD | -16.88% |
| 2012 FY | 1.66 Million USD | 132.45% |
| 2012 Q3 | 738 Thousand USD | -11.3% |
| 2011 Q3 | 643 Thousand USD | -7.88% |
| 2011 Q4 | 629 Thousand USD | -2.18% |
| 2011 FY | 715 Thousand USD | -25.75% |
| 2011 Q2 | 698 Thousand USD | -15.39% |
| 2011 Q1 | 825 Thousand USD | 0.0% |
| 2010 Q3 | 887 Thousand USD | 0.57% |
| 2010 FY | 963 Thousand USD | 36.02% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q2 | 882 Thousand USD | 20.33% |
| 2010 Q1 | 733 Thousand USD | 3.53% |
| 2009 Q4 | 708 Thousand USD | 11.85% |
| 2009 FY | 708 Thousand USD | -64.67% |
| 2009 Q3 | 633 Thousand USD | 0.0% |
| 2008 FY | 2 Million USD | -63.98% |
| 2008 Q4 | 2 Million USD | 0.0% |
| 2008 Q2 | 6.64 Million USD | 0.0% |
| 2007 Q4 | 5.56 Million USD | 0.0% |
| 2007 Q2 | 4.48 Million USD | 0.0% |
| 2007 FY | 5.56 Million USD | 34.37% |
| 2006 Q2 | 4.14 Million USD | 0.0% |
| 2006 FY | 4.14 Million USD | 6.18% |
| 2006 Q4 | 4.14 Million USD | 0.0% |
| 2005 Q4 | 3.89 Million USD | 0.0% |
| 2005 Q2 | 4.82 Million USD | 0.0% |
| 2005 FY | 3.89 Million USD | -35.25% |
| 2004 FY | 6.02 Million USD | 41.86% |
| 2004 Q4 | 6.02 Million USD | 0.0% |
| 2004 Q2 | 5.77 Million USD | 0.0% |
| 2003 FY | 4.24 Million USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Matricelf Ltd | 3.7 Million ILA | 94.432% |